JAZZ vs VC · P/E 1988, rev $4.07B vs P/E 18, rev $3.87B
Jazz Pharmaceuticals PLC (JAZZ) versus Visteon Corp (VC) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Visteon Corp (VC) is a auto parts company listed on NASDAQ.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported VC revenue for 2024-12-31 was $3.87B. Net income was $284.0M. Revenue was down 2.2% from 2023-12-31 to 2024-12-31. VC currently screens at market cap $2.95B and trailing P/E 18.5.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. VC currently screens at market cap $2.95B and trailing P/E 18.5.
Not investment advice. Open the JAZZ and VC stock pages for the full models.
Not investment advice.